ÜRE, İ. And Ozen, A. 2021. Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie's disease: A single-centre, preliminary prospective non-randomised study. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75 .

ÜRE, İ., & Ozen, A., (2021). Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie's disease: A single-centre, preliminary prospective non-randomised study. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75.

ÜRE, İYİMSER, And ATA ÖZEN. "Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie's disease: A single-centre, preliminary prospective non-randomised study," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, 2021

ÜRE, İYİMSER And Ozen, ATA. "Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie's disease: A single-centre, preliminary prospective non-randomised study." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, 2021

ÜRE, İ. And Ozen, A. (2021) . "Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie's disease: A single-centre, preliminary prospective non-randomised study." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75.

@article{article, author={İYİMSER ÜRE And author={ATA ÖZEN}, title={Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie's disease: A single-centre, preliminary prospective non-randomised study}, journal={INTERNATIONAL JOURNAL OF CLINICAL PRACTICE}, year=2021}